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Background: Rhabdomyomas are the most common type of cardiac tumors in children. Anatomically, they can be
considered as hamartomas. They are usually randomly diagnosed antenatally or postnatally sometimes presenting
in the neonatal period with haemodynamic compromise or severe arrhythmias although most neonatal cases
remain asymptomatic. Typically rhabdomyomas are multiple lesions and usually regress spontaneously but are
often associated with tuberous sclerosis complex (TSC), an autosomal dominant multisystem disorder caused by
mutations in either of the two genes, TSC1 or TSC2. Diagnosis of tuberous sclerosis is usually made on clinical
grounds and eventually confirmed by a genetic test by searching for TSC genes mutations.
Methods: We report our experience on 33 cases affected with rhabdomyomas and diagnosed from January 1989
to December 2012, focusing on the cardiac outcome and on association with the signs of tuberous sclerosis
complex. We performed echocardiography using initially a Philips Sonos 2500 with a 7,5/5 probe and in the last
4 years a Philips IE33 with a S12-4 probe. We investigated the family history, brain, skin, kidney and retinal lesions,
development of seizures, and neuropsychiatric disorders.
Results: At diagnosis we detected 205 masses, mostly localized in interventricular septum, right ventricle and left
ventricle. Only in 4 babies (12%) the presence of a mass caused a significant obstruction. A baby, with an enormous
septal rhabdomyoma associated to multiple rhabdomyomas in both right and left ventricular walls died just after
birth due to severe heart failure. During follow-up we observed a reduction of rhabdomyomas in terms of both
number and size in all 32 surviving patients except in one child. Eight patients (24,2%) had an arrhythmia and in 2
of these cases rhabdomyomas led to Wolf-Parkinson-White Syndrome. For all patients the arrhythmia spontaneously
totally disappeared or was reduced gradually. With regarding to association with tuberous sclerosis, we diagnosed
tuberous sclerosis clinically in 31 babies (93,9%).
Conclusion: Rhabdobyomas are tumors with favorable prognosis because they frequently do not cause symptoms
and they often regress in numbers and size. Nevertheless, due to frequent association with tuberous sclerosis
complex and the resulting neurological impairment, the prognosis can result unfavorable.
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Rhabdomyomas are the most frequent cardiac tumors in
children followed by fibromas (25% to 30%) [1,2] and less
commonly by myxoma, lipoma, teratoma, hemangioma,
mesothelioma and Purkinje cell tumour. They are often
associated to tuberous sclerosis complex (TSC) [3]. This is
an autosomal dominant neurocutaneous disorder that can
affect every organ of the body, most commonly the brain,
kidney, heart, and lungs [4]. We report our experience
with regard to 33 patients with multiple cardiac rhabdmio-
mata masses, focusing on cardiac outcome and on the
association with tuberous sclerosis complex.
Methods
From January 1989 to December 2012 in the Pediatric
Cardiology Unit of University of Catania echocardiog-
raphy was performed in 14238 patients below twelve
months of age using initially a Philips Sonos 2500 with a
7,5/5 probe and in the last 4 years a Philips IE33 with a
S12-4 probe.
Every patient if of age, or at least one parent or legal
guardian if underage, gave their written informed con-
sent before the patient’s inclusion in the study. The
study was conducted in accordance with the Helsinki
Declaration, and the study protocol was approved by the
(local) Ethics Committee of the Medical University of
Catania.
Rhabdomyomas were identified in 33 cases (0,23%). We
identified all these patients (Table 1) from the database of
our Department of Pediatrics. Clinical features of postnatal
examinations were documented from pediatric records and
echocardiographic images reviewed from the computer
database. Data included age at diagnosis, clinical presenta-
tion, physical examination findings (cyanosis, heart mur-
mur, arrhythmia, heart failure), electrocardiogram (ECG),
24-hour ECG recording results, initial and last echocardi-
ography findings (number of rhabdomyomas, location,
presence of inflow or outflow tract obstruction, myocardial
dysfunction), indication for surgery, outcome (partial or
total regression, residual tumors), and follow-up period.
Thirty one infants with diagnosis of Tuberous Sclerosis
Complex were identified among those who were initially
diagnosed having cardiac rhabdomyomas.
We assessed cerebral lesions and development of neuro-
logical and skin signs, and eventually kidney and eye in-
volvement in all patients affected by tuberous sclerosis
(Table 2). Diagnosis of TSC was based on clinical criteria
established in 1998 by the US Tuberous Sclerosis Com-
plex Association [5]. Genetic test for TSC is available on 3
patients (9%) and all are positive.
Follow-up consisted of clinical case review as well as
records of investigationswas: subsequent to the diagnosis,
all babies were subjected to at least 18 months cardiac
follow-up with ECG, color Doppler echocardiography andHolter-ECG every six months. Regarding TSC, under
the supervision of a pediatric neurologist, we performed
skin and ophthalmological examinations, abdomen ultra-
sound examination, assessment of occurrence of seizures,
brain MRI, aimed at highlighting the typical lesions of
tuberous sclerosis complex, and evaluation of mental
retardation, psychomotor delay or behavioral and language
disorders (the follow-up was between six months and
ten years).
Results
At diagnosis we detected 205 masses: 6 (2,9%) in right
atrium, 1 (0,5%) in left atrium, 4 (1,9%) close to valves,
16 (7,8%) in the right infundibulum, 75 (36,6%) in inter-
ventricular septum, 45 (22%) in right ventricular wall, 58
(28,3%) in left ventricular wall. In 10 cases (30,3%) rhab-
domyomas had been detected antenatally with fetal
echocardiography and confirmed at birth. For the other
patients, the indications to perform the first echocardio-
graphic assessment were arrhythmias, such as, atrial
and/or ventricular ectopic beats in 2 cases (6,1%), in 1
case (3%) the appearance of seizures as infantile spasms,
in 2 cases (6,1%) occurrence of cyanosis, in 11 (33,3%)
cases presence of a heart murmur, whereas 7 cases (21,2%)
were found during routine screening. The mean age in
postnatally diagnosed patients was 74,6 days. In 31
patients (94%) we detected multiple masses that led us
to define these as rhabdomyomas. Only in 2 patients
(6,1%) we observed a single cardiac mass, one intra-
mural in the interventricular septum and one protrud-
ing in right ventricular cavity respectively. Of these two,
TSC was diagnosed only in one.
In 4 babies (12%) the presence of a mass caused a sig-
nificant obstruction and/or clinical signs of heart failure
and/or cyanosis due to right or left ventricular outflow
tract obstruction. Among these 4, in a newborn (3%),
with a diagnosis of cardiac masses in the fetal period,
surgery to remove the mass was carried out because of
severe signs of heart failure and cyanotic spells; a new-
born (3%), with antenatal diagnosis of an enormous sep-
tal rhabdomyoma associated to multiple rabdomyomas
in both right and left ventricular wall, died soon after
birth, due to a severe heart failure; whereas in the other
2 patients, with left and right ventricular obstruction re-
spectively, obstructing rhabdomyomas decreased in terms
of size without need of medication. Moreover, in another
patient (3%) echocardiography revealed only slight hypo-
kinesia without need for medical or surgical therapy.
The other 28 patients (85%) did not show signs of
hemodynamic impairment.
During follow-up we observed a reduction of rhabdo-
myomas in terms of both number and size in all 32
surviving patients except in one child. We detected 102
masses: 2 (2%) in right atrium, none (0%) in left atrium,





Clinical signs at first
examination




1 2 months Arrhythmia Atrial and ventricular ectopic beats Multiple rhabdomyomas No
WPW Syndrome
2 1 month Heart murmur Normal Multiple rhabdomyomas No
3 2 months Heart murmur Widened QRS Multiple rhabdomyomas No
4 Fetal No symptoms but RVOT
obstruction
Normal Multiple rhabdomyomas No
5 1 day Heart murmur Normal Multiple rhabdomyomas No
LV obstruction
6 1 day Heart murmur Normal Multiple rhabdomyomas No
7 Fetal No symptoms RV hypertrophy Lobulated mass in LV No
8 Fetal No symptoms Normal Multiple rhabdomyomas No
9 1 month Heart murmur RV hypertrophy Lobulated mass in IVS No
10 1 day Cyanosis Atrial and ventricular ectopic beats Multiple rhabdomyomas No
LV obstrution
11 2 months No symptoms Atrial ectopic beats Multiple rhabdomyomas No
12 1 months No symptoms RV overload signs Multiple rhabdomyomas No
13 Fetal Heart failure Cyanosis Atrial and ventricular ectopic beats Multiple rhabdomyomas Yes
14 1 day Heart murmur Normal Multiple rhabdomyomas No
15 7 months Heart murmur Atrial and ventricular ectopic beats Multiple rhabdomyomas No
WPW Syndrome
16 1 day No symptoms Incomplete right bundle branch block Multiple rhabdomyomas No
17 9 months Heart murmur Normal Multiple rhabdomyomas No
18 1 day Arhythmia Atrial and ventricular ectopic beats Multiple rhabdomyomas No
19 Fetal No symptoms (hypokinesia) Normal Multiple rhabdomyomas No
20 4 months Heart murmur Ventricular ectopic beats and RV overload
signs
Multiple rhabdomyomas No
21 Fetal No symptoms WPW Syndrome Multiple rhabdomyomas No
IVS overload signs
22 3 days Heart murmur Normal Multiple rhabdomyomas No
23 11 months No symptoms RV overload signs Multiple rhabdomyomas No
24 5 months No symptoms Atrial and ventricular ectopic beats Multiple rhabdomyomas No
25 1 day Heart murmur Normal Multiple rhabdomyomas No
26 9 months Seizures Normal Multiple rhabdomyomas No
27 Fetal No symptoms Normal Multiple rhabdomyomas No
28 2 months No symptoms Normal Multiple rhabdomyomas No
29 Fetal No symptoms RV overload signs Multiple rhabdomyomas No
30 Fetal Heart murmur Normal Multiple rhabdomyomas No
31 7 days Heart murmur Normal Multiple rhabdomyomas No
32 21 days No symptoms RV hypertrophy Multiple rhabdomyomas No
33 Fetal Heart murmur Ventricular ectopic beats Multiple rhabdomyomas No
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(39,2%) in interventricular septum, 25 (24,5%) in right
ventricular wall, 27 (26,5%) in left ventricular wall. In 8
cases (24,2%) we found atrial and/or ventricular ectopicbeats and in 2 of these cases rhabdomyomas led to
Wolf-Parkinson-White Syndrome. For all patients, drug
treatment was not believed necessary and the arrhythmia
spontaneously healed or was gradually reduced.





MRI Skin lesions Others Family history











































Subependymal nodules Facial angiofibroma
Psychomotor
delay
Cerebral white matter radial
migration lines
Forehead plaque










Subependymal nodules Facial angiofibroma
Mental retardation Subependymal giant cell
astrocytoma
Behavior disorders
9 Lobulated mass in
IVS
No Not performed Hypomelanotic
maculae
No Negative










Cerebral white matter radial
migration lines






13 Heart failure and
cyanosis
West syndrome Subependymal nodules Hypomelanotic
maculae
No Negative
Sciacca et al. BMC Cardiovascular Disorders 2014, 14:66 Page 4 of 11
http://www.biomedcentral.com/1471-2261/14/66
Table 2 General clinical presentation – heart, brain, skin, eye and kidney involvement - and family history (Continued)
Atrial and ventricular
ectopic beats
Behavior disorders Subependymal giant cell
astrocytoma Cerebral white












Mental retardation Subependymal nodule







WPW Syndrome Behavior and
language
disorders
Subependymal nodule Facial angiofibroma
Multiple
rhabdomyomas
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Behavior disorders Subependymal nodule







23 RV overload signs Drug resistant
epilepsy







Mental retardation Facial angiofibroma
Forehead plaque
24 Atrial and ventricular
ectopic beats
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Table 2 General clinical presentation – heart, brain, skin, eye and kidney involvement - and family history (Continued)





















Subependymal nodules Facial angiofibroma
Mental retardation Forehead plaque
28 Multiple
rhabdomyomas
West syndrome Cortical tubers Hypomelanotic
maculae
Retinal hamartoma Negative
Behavior disorders Subependymal nodules Facial angiofibroma









West Syndrome Cortical tubers Hypomelanotic
maculae
No Positive for TSC
Cerebral white matter radial
migration lines







Mental retardation Subependymal nodules Renal angiomyolipoma
32 Multiple
rhabdomyomas
West Syndrome Cortical tubers Hypomelanotic
maculae
No Negative
Mental retardation Subependymal nodules Facial angiofibroma
Cerebral white matter radial
migration lines







Mental retardation Subependymal nodules Facial angiofibroma
Cerebral white matter radial
migration lines
Forehead plaque
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(Table 2), we diagnosed tuberous sclerosis clinically in
31 babies (93,9%) and confirmed diagnosis in 3 patients
(9%) by genetic tests. Familial history of the disease was
positive in 8 cases (24,2%).
MRI of brain was performed in 30 children and re-
vealed the characteristic lesions of tuberous sclerosis in
29 (96,6%): cortical tubers in 24 patients (80%), subepen-
dymal nodules in 16 (53,3%), subependymal giant cell
astrocytoma in 4 (13,3%) and cerebral white matter
radial migration lines in 12 (40%). Often two or more
lesions coexisted in the same patients.
Of 31 affected, 25 (80,6%) developed seizures during
follow-up and we cannot exclude symptoms in the future
for the remaining. In particular, West Syndrome waspresent in 16 children (54,3%), Lennox-Gastaut in 3 (9,6%),
partial seizures in 5 (16,1%) and drug resistant epilepsy in
5 (16,1%). Moreover mental retardation was present in 9
(29%), psychomotor delay in 5 (16,1%), behavior disorders
in 5 (16,1%) and language disorders in 1 (3,2%).
With regrads to skin lesions, we noticed hypomelanotic
macules in all 31 patients with tuberous sclerosis (100%),
facial angiofibroma in 14 (45,1%) and forehead plaque in 6
(19,3%). Concerning the involvement of other organs, we
detected retinal hamartoma in 13 (41,9%), renal angio-
myolipoma in 5 (16,1%) and renal cysts in 2 (6,4%).
Discussion
Cardiac tumours are extremely rare in children (0.027 to
0.17%) [6]. More than one-half of pediatric cardiac tumors
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diagnosed both in prenatal and postnatal period [7]. The
vast majority of primary cardiac tumours in children are
benign, whilst approximately 10% are malignant [8].
Rhabdomyomas are the most common cardiac tumours
in children (45%) [9,10].
Echocardiography has been estabilished as the primary
diagnostic tool for the evaluation of cardiac tumors in chil-
dren [11]. Rhabdomyomas appear on ultrasound as round,
homogeneous, hyperechogenic, intramural or intracavitary
masses, sometimes multiple [12], predominantly localized
within the ventricles but can be observed in the atria or
caval veins and may lead to obstruction of cardiac valves
or inflow/outflow tracts. They are typically asymptomatic
but may also cause atrial or ventricular arrhythmias, sinus
node dysfunction, heart block and pre-excitation [2,9].
Surgical resection is not usually considered unless they
cause severe intractable arrhythmias, valvular obstruction,
or congestive heart failure [13]. In any case they are often
difficult to remove completely, because they are usually
located deep in the myocardium [14].
In our patients rhabdomyomas were mostly placed in
the ventricles (94%), but also in the right atrium (2,9%),
left atrium (0,5%) and/or valves (1,9%). Most masses led
only to a heart murmur (33,3%) or were identified inciden-
tally (21,2%) during echocardiography, but also were re-
ferred rarely due to cyanosis (6,1%) or arrhythmias (24,2%)
that totally disappeared or gradually decreased over time.
Only one case with signs of heart failure was subjected to
surgical resection with good results. Nevertheless, another
baby, with severe left ventricular outflow obstruction
due to a giant septal rhabdomyomas (Figures 1, 2, 3), died
soon after birth.Figure 1 Giant fetal rhabdomyoma.Congenital cardiac rhabdomyomas represent a condi-
tion of particular interest for the researcher due to spon-
taneous regression of the tumours that occurs in more
than one-half of cases [7].
Jozwiak et al. reported that partial resolution of the
cardiac rhabdomyomas was reported in 50% of cases
and complete regression in 18% and added that these
tumors have been reported to grow or to appear de novo
in 4% of patients with tuberous sclerosis [15]. Smith
et al. showed similar data: regression rates of 60% in pre-
adolescent tuberous sclerosis patients and 18% in adult
tuberous sclerosis patients [16,17].
In our experience we noticed involution of rhabdomyo-
mas in all cases with reduction of number and size, with a
decrease of all masses in 51,3%, confirming indirectly the
histological observations that these lesions regress.
To explain the involution tendency we refer to patho-
logical anatomy: tumours consist of pathognomonic spider
cells with centrally placed cytoplasm containing the nu-
cleus and myofibrils radiating to the cell wall [18]. These
tumours that seem to originate from embryonic myocytes,
represent hamartomas of striated muscular fibers occur-
ring solely in the heart [14].
Immunohistochemical immunoreactivity with ubiqui-
tin, associated with the degradation of myoflaments,
progression of cytoplasmic vacuolization, enlargement of
glycogen vacuoles, apoptosis and myxoid degeneration
are the events providing a plausible explanation for the
spontaneous regression of rhabdomyoma [17]. In other
words, the involution may be related to the inability of
the tumours to divide while the heart chambers grow
[19] and this consideration may indicate that some still
incompletely identified factors, involved in homeostatic
Figure 2 Giant rhabdomyoma in left ventricle.
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the masses. Infact, after birth, rhabdomyoma cells lose
their ability to divide and regression of the tumour in
infancy is an expected outcome, regardless of size of the
tumour [20-22]. Complete resolution of more than 80%
of the tumours may occur during early childhood [23].
Regression may leave a scarred thin chamber wall [7].
The outcome of antenatally detected cardiac rhabdo-
myomas is also favorable. Once fetal somatic growth is
completed, hamartomas lose their mitotic potential and
undergo apoptosis [24]. The majority of tumours will
regress towards the end of the third trimester althoughFigure 3 Giant rhabdomyoma – long axis.rarely some may continue to grow larger. Despite the
expected shrinkage of these tumours, unexpected fetal
loss may occur due to arrhythmias or obstruction of
blood flow [20-22].
Rhabdomyomas can be sporadic but [2,9] in many
cases they are associated with tuberous sclerosis com-
plex (TSC) [25]. This is an inherited multiorgan disease
with birth incidence of approximately 1 per 5,000 to
10,000 live births. It is an autosomal dominant neurocu-
taneous disorder characterized by tumor-like malforma-
tions that involve many organ systems, including the
brain, heart, kidneys and skin [26].
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to de novo mutations [27].
It is caused by mutations in either of the two genes,
TSC1 or TSC2, which code for the proteins hamartin
(chromosome 9q34) and tuberin (chromosome 16p13),
respectively, that act as tumour-growth suppressors [28].
Hamartin and tuberin form a complex that activates the
GTPase-activating protein Rheb to inhibit the mammalian
target of rapamycin (mTOR). mTOR is a highly specific
protein kinase that regulates protein synthesis, cellular
metabolism, differentiation, growth, and migration. Con-
stitutive activation of mTOR results in the abnormal cellu-
lar proliferation and differentiation responsible for the
multiple hamartomatous growths throughout the central
nervous system, lungs, heart, kidneys, eyes and skin [29].
In our experience rhabdomyomas were associated with
tuberous sclerosis in a high number of cases (93,9%) and
we found a familial history positive for tuberous sclerosis
in about a quarter of cases (25,8%).
Our data mostly conform with the literature in that
rhabdomyomas are strong predictors of TSC both when
prenatally but especially when postnatally diagnosed
[12,30,31].
It is reported that 60-80% of children affected by
tuberous sclerosis have cardiac rhabdomyomas, whereas
these tumors can be found in only around 20% of adults
with tuberous sclerosis [19].
In our series almost all children had multiple rhabdo-
myomas (Figures 4 and 5) with diagnosis of TSC (96,7%).
Although the association of multiple cardiac rhabdomyo-
mas with tuberous sclerosis has long been recognized, the
association with a single rhabdomyoma is not clear.Figure 4 Multiple rhabdomyomas – 4 chambers.However, in case of a solitary tumour a careful examin-
ation of cardiac chambers should be made in order not to
miss smaller lesions elsewhere [32,33].
The diagnosis of TSC is made clinically. A clinical
scoring system was developed that divides the diagnostic
criteria for TSC into major and minor features. Single or
multiple cardiac rhabdomyomas are considered a major
feature.
However, the expression and the severity of the disease
show substantial variation within, as well as between,
families. The classical diagnostic triad of seizures, mental
retardation, and facial angiofibromas occurs in fewer
than half of the patients [5].
Neurologic manifestations are the most common; 90%
of affected people experience seizures, and ∼ 30% to 40%
have mental retardation or autism [34,35].
Other signs of tuberous sclerosis include cutaneous
lesions, such as, angiofibromas, shagreen patches and
hypopigmented macules, brain lesions, such as, cortical/
subcortical tubers, subependymal nodules, subependy-
mal giant cell astrocytomas and white matter lesions as
well as renal and liver angiomyolipoma, retinal glial
hamartomas and cysts in various locations, including the
liver, kidneys and pancreas [36].
During follow-up our patients developed seizures in
80,6% of cases and we cannot exclude that the rest of the
patients might develop them subsequently. West Syn-
drome represented the most frequent epilepsy occurring
in 54,3% of the cases followed by partial seizures in 16,1%,
drug resistant epilepsy (16,1%) and Lennox-Gastaut in
9,6%. Other signs of neurological impairment were mental
retardation (29%), psychomotor delay (16,1%), behavior
Figure 5 Multiple rhabdomyomas.
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garding the brain lesions, they were present in almost all
of these patients (96,6%) and they mostly showed cortical
tubers (80%). Also the other lesions characteristic of TSC
were present: subependymal nodules in few more than
half of cases (53,3%), cerebral white matter radial migra-
tion lines in less than half of cases (40%) and, rarely, sube-
pendymal giant cell astrocytoma in only 13,3% of patients.
Often two or more lesions coexisted in the same patient.
Finally, about the other lesions of TSC, we found hypome-
lanotic macules in all, facial angiofibroma in 45,1% and
shagreen patches in only 19,3%. We detected retinal
hamartoma in almost half of cases (41,9%), renal angio-
myolipoma in 16,1% and renal cysts in only 6,4%. We
cannot exclude that other lesions may develop over time.
Our data suggest that if the prognosis of rhabdomyo-
mas in usually favorable, it is also true that in cases
associated with tuberous sclerosis the general prognosis
might be worsened by onset of seizures or lesions in
other organs later in life.Conclusions
Although there are no consistent guidelines, cardiac moni-
toring must be carried out for all tuberous sclerosis
patients with rhabdomyomas, with serial echocardiography
every 6 months and annual Holter monitoring, even if
most patients are usually free from cardiac symptoms. Des-
pite the potentially favourable prognosis of patients with
cardiac rhabdomyomas, their presence should be sought
(by echocardiography) in patients with tuberous sclerosis.
Regarding relation between rhabdomyomas and tuber-
ous sclerosis we must consider that despite the potentially
favourable cardiac evolution of patients with cardiacrhabdomyomas, their presence suggests a tuberous sclerosis
with a neurological prognosis that is not related to the
number or the dimensions of rhabdomyomas.
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